Publications by authors named "A Henseler"

Plasma IL-6 is elevated after myocardial infarction (MI) and is associated with increased morbidity and mortality. Which cardiac cell type preferentially contributes to IL-6 expression and how its production is regulated are largely unknown. Here, we studied the cellular source and purinergic regulation of IL-6 formation in a murine MI model.

View Article and Find Full Text PDF

Purpose: The optimal dose intensity for conditioning prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) for chronic lymphocytic leukemia (CLL) is unknown.

Methods: We retrospectively compared outcomes of patients who received a first alloHCST after non-myeloablative (NMA) and reduced intensity conditioning (RIC). Data of 432 patients with a median age of 55 years were included, of which 86 patients underwent NMA and 346 RIC.

View Article and Find Full Text PDF

Current left ventricular assist devices are designed to reestablish patient's hemodynamics at rest but they lack the suitability to sustain the heart adequately during physical exercise. Aim of this work is to assess the performance during exercise of a left ventricular assist device with flatter pump pressure-flow characteristic and increased pressure sensitivity (left ventricular assist device 1) and to compare it to the performance of a left ventricular assist device with a steeper characteristic (left ventricular assist device 2). The two left ventricular assist devices were tested at constant rotational speed with a verified computational cardiorespiratory simulator reproducing an average left ventricular assist device patient response to exercise (EXE↑) and a left ventricular assist device patient with no chronotropic and inotropic response (EXE→).

View Article and Find Full Text PDF

Current left ventricular assist devices (LVADs) differ with respect to their pump characteristics as described by the pump characteristic curve (also called HQ-curve). Pressure sensitive LVADs depict a flat characteristic curve while most available LVADs have a steep, less pressure sensitive characteristic curve. This in vitro study investigated the effect of LVAD pressure sensitivity with a focus on the afterload of the right ventricle (RV) which is one out of many factors influencing right heart failure (RHF).

View Article and Find Full Text PDF
Article Synopsis
  • Patients with high-risk chronic lymphocytic leukemia experience shorter progression-free survival (PFS) when treated with kinase- and BCL2-inhibitors; however, allogeneic hematopoietic stem cell transplantation (alloHCT) may offer better long-term outcomes, particularly for younger patients.
  • A study involving 197 patients under 50 years identified key factors impacting 2-year non-relapse mortality (NRM) and 8-year PFS, with findings showing that being in remission and having a well-matched donor significantly improved prognosis.
  • The research suggests that younger patients with high cytogenetic risk may have better survival rates with alloHCT compared to traditional therapies, making it a promising treatment option despite uncertainty
View Article and Find Full Text PDF